This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
RNA breakthroughs, Case Studies and Partnerships
September 10-11, 2025Thomas M. Menino Convention & Exhibition Center

Sudhir Agrawal
President and Founder at Arnay Sciences
Speaker

Profile

Sudhir Agrawal, D. Phil., FRSC, is the founder and President of ARNAY Sciences LLC. Over the past thirty years, his research has focused on discovering and developing RNA therapeutics, including antisense and immunotherapy. Recently, his work has involved the chemical engineering of oligonucleotides, including the creation of transient cyclic structures for use in developing RNA therapeutics with various mechanisms of action. He has published over 300 research papers and is listed as a co-inventor on more than 400 patents worldwide. He has edited four books on oligonucleotides and antisense technology, including a recent publication on ‘Advances in Nucleic Acid Therapeutics’. Currently, he serves on the scientific advisory boards of multiple biotechnology companies dedicated to developing RNA therapeutics.

Agenda Sessions

  • Transient Spatial Configurations of Oligonucleotides: Wide-ranging Uses in RNA Therapeutic Development

    11:15am